Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Mahmutovic Persson (Malmö, Sweden), K. Wachenfeldt (Lund, Sweden), K. Pindoria (Stevenage, United Kingdom), J. Delgado-San Martin (Stevenage, United Kingdom), S. Campbell (Stevenage, United Kingdom), M. Haase (Stevenage, United Kingdom), M. Wright (Stevenage, United Kingdom), J. Waterton (Manchester, United Kingdom), L. Olsson (Malmö, Sweden). Systematic review: In vivo imaging in animal models relevant to drug-induced Interstitial lung disease (DIILD). 2956

Member's Comments

No comment yet.

Related content which might interest you: Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020 Year: 2021 Interstitial lung disease in childhood. A clinical review Source: Eur Respir J 2004; 24: Suppl. 48, 624s Year: 2004 Drug induced interstitial lung disease: a systematic review Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Systematic review of drug effects in humans and models with surfactant-processing disease Source: Eur Respir Rev, 27 (149) 170135; 10.1183/16000617.0135-2017 Year: 2018 Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001 Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence Source: Eur Respir Rev, 27 (150) 180074; 10.1183/16000617.0074-2018 Year: 2018 Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review Source: ERJ Open Res, 7 (4) 00441-2021; 10.1183/23120541.00441-2021 Year: 2021 Oxygen therapy for interstitial lung disease: a systematic review Source: Eur Respir Rev 2017; 26: 160080 Year: 2017 3he MRI and an animal model of interstitial lung disease Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009 Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD) Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Longitudinal micro-CT of preclinical models of lung disease provides biomarkers of disease and therapy that reveal compensatory changes in lung volume Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Rituximab-induced lung disease. Case and review Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Preclinical studies of mesenchymal stem cell (MSC) transplantation in chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 3D-simulation in an integrated assessment of the dynamics in patients with disseminated pulmonary lesions (DPL) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Synoptical table of idiopathic interstital pneumonia (IIP) findings in computed tomography (CT) – A practical tool and systematic review Source: International Congress 2014 – ILDs 5 Year: 2014 Biomarkers for fibrotic lung disease - new clinical benchmarks from the lab? Source: Annual Congress 2013 –ME3 Biomarkers for fibrotic lung disease – new clinical benchmarks from the lab? Year: 2013 Prediction models for the development of COPD: a systematic review Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Molecular imaging of the progression of pulmonary fibrosis using animal models of disease Source: Eur Respir J 2006; 28: Suppl. 50, 605s Year: 2006 MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases. Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018